Yarrow Bioscience (YARW) Total Non-Current Liabilities (2016 - 2024)

Yarrow Bioscience (YARW) has reported Total Non-Current Liabilities for 8 consecutive years, with $25000.0 the latest figure, recorded in Q2 2024.

• For the quarter ending Q2 2024, Total Non-Current Liabilities fell 99.61% year-over-year to $25000.0; the trailing twelve-month figure through Jun 2024 stood at $25000.0 (down 99.61% YoY), and the FY2023 full-year result was $1.4 million, changed N/A from the prior year.
• Total Non-Current Liabilities declined to $25000.0 in Q2 2024 per YARW's latest filing, from $1.4 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $58.6 million in Q2 2021 and bottomed at $25000.0 in Q2 2024.
• Historically, Total Non-Current Liabilities has averaged $23.0 million across 4 years, with a median of $22.0 million in 2021.
• The sharpest annual moves came in 2021 and 2024: Total Non-Current Liabilities jumped 67.15% in 2021, then slumped 99.61% in 2024.
• Over 4 years, Total Non-Current Liabilities stood at $34.5 million in 2020, then plunged by 36.27% to $22.0 million in 2021, then plunged by 93.58% to $1.4 million in 2023, then tumbled by 98.23% to $25000.0 in 2024.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $25000.0, $1.4 million, and $1.4 million for Q2 2024, Q1 2024, and Q4 2023 respectively.